Inform Genomics Transplant Product Shown to Predict Oral Mucositis with a High Degree of Accuracy in Patients Undergoing Conditioning Regimens Prior to Hematopoetic Stem Cell Transplant
11 déc. 2012 08h00 HE
|
Inform Genomics
Boston, MA, Dec. 11, 2012 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based personalized medicine products for
cancer supportive...
Inform Genomics Presents Results For OnPART(tm) Showing High Degree Of Accuracy Predicting Six Common Side Effects Of Dose Dense Chemotherapy
06 déc. 2012 09h50 HE
|
Inform Genomics
Boston, MA, Dec. 6, 2012 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based personalized medicine products for
cancer supportive...
Inform Genomics Announces Positive Top-Line Results in First Phase of Development for OnPART(TM) Personalized Medicine Product
01 oct. 2012 08h00 HE
|
Inform Genomics
Boston, MA, Oct. 1, 2012 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a private company focused on developing
novel platforms of genomic-based personalized medicine products for
cancer supportive care...